NS2B/3 proteolysis at the C-prM junction of the tick-borne encephalitis virus polyprotein is highly membrane dependent  by Kurz, Martina et al.
N
p
M
M
a
A
R
R
A
A
K
P
F
S
M
R
H
1
o
a
t
R
f
T
p
u
a
t
e
N
0
hVirus Research 168 (2012) 48–55
Contents lists available at SciVerse ScienceDirect
Virus Research
journa l homepage: www.e lsev ier .com/ locate /v i rusres
S2B/3 proteolysis at the C-prM junction of the tick-borne encephalitis virus
olyprotein is highly membrane dependent
artina Kurz, Nikolas Stefan1, Junping Zhu2, Tim Skern ∗
ax F. Perutz Laboratories, Medical University of Vienna, Dr. Bohr-Gasse 9/3, A-1030 Vienna, Austria
 
 
 
 
 
 
r t i c l e
 
 
 
 
i n f o
rticle history:
eceived 23 February 2012
eceived in revised form 11 June 2012
ccepted 11 June 2012
vailable online 19 June 2012
eywords:
roteolytic processing
lavivirus
ignal peptidase
icrosomal membranes
ibosomal skip
IV protease
 
 
 
 
 
 
 
a b s t r a c t
The replication of tick-borne encephalitis virus (TBEV), like that of all ﬂaviviruses, is absolutely dependent
on proteolytic processing. Production of the mature proteins C and prM from their common precursor
requires the activity of the viral NS2B/3 protease (NS2B/3pro) at the C-terminus of protein C and the host
signal peptidase I (SPaseI) at the N-terminus of protein prM. Recently, we have shown in cell culture
that the cleavage of protein C and the subsequent production of TBEV particles can be made dependent
on the activity of the foot-and-mouth disease virus 3C protease, but not on the activity of the HIV-1
protease (HIV1pro) (Schrauf et al., 2012). To investigate this failure, we developed an in vitro cleavage
assay to assess the two cleavage reactions performed on the C-prM precursor. Accordingly, a recombi-
nant modular NS2B/3pro, consisting of the protease domain of NS3 linked to the core-domain of cofactor
NS2B, was expressed in E. coli and puriﬁed to homogeneity. This enzyme could cleave a C-prM protein
synthesised in rabbit reticulocyte lysates. However, cleavage was only speciﬁc when protein synthesis
was performed in the presence of canine pancreaticmicrosomalmembranes and required the prevention
of signal peptidase I (SPaseI) activity by lengthening the h-region of the signal peptide. The presence of
promembranes allowed the concentration of NS2B/3 used to be reduced by 10–20 fold. Substitution of the
NS2B/3pro cleavage motif in C-prM by a HIV-1pro motif inhibited NS2B/3pro processing in the presence of
microsomal membranes but allowed cleavage by HIV-1pro at the C-prM junction. This system shows that
processing at the C-terminus of protein C by the TBEV NS2B/3pro is highly membrane dependent and will
allow the examination of how the membrane topology of protein C affects both SPaseI and NS2B/3pro
processing. 
 
 
 
 
 
 
 
 
 
. Introduction
Tick-borne encephalitis virus (TBEV), a member of the family
f Flaviviridae in the genus Flavivirus (Lindenbach et al., 2007) is
small (∼50nm) enveloped virus with a single stranded, posi-
ive sense RNA genome. In addition to the lipid envelope and the
NA, three structural proteins (capsid (C), membrane (M, derived
rom a precursor prM) and envelope (E)) are present in the virion.
he genetic information in the viral RNA is expressed as a single
olyprotein that meanders in and out of the endoplasmic retic-
lum (ER) membrane. The structural proteins are located in the
mino-terminal part of the polyprotein; the rest of the polypro-
ein comprises the non-structural proteins NS1, NS2A, NS2B, NS3,
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NS4A, NS4B, and NS5 (Lindenbach et al., 2007). NS2B and NS3 (des-
ignatedhereNS2B/3pro) comprise the viral protease that is required
for polyprotein processing, along with furin and signal peptidase
I (SPaseI), two host cell proteases. These cleavages occur co- and
post-translationally. In addition, during translation and processing,
the surface proteins prM and E are glycosylated in the lumen of the
ER. The production of these structural proteins is vital as protein C
is the initiator molecule for viral assembly; multiple copies of this
protein encapsidate a newly synthesised RNA molecule to produce
the nucleocapsid (NC). Furthermore, prM is required to ensure that
protein E is manufactured in a viable conformation. Correctly pro-
cessed prM and E are added to the growing particle by budding of
the NC through the ER. The resulting immature particles cross the
trans-Golgi network (TGN), permitting furin cleavage of prM; this
reaction transforms the immature particles into infectious virions
(Stadler et al., 1997).
Processing is thus a prerequisite for the assembly of the 
 
 
 
 
 
 
 
TBEV particle; not surprisingly, the two processes are closely co-
ordinated (Lobigs, 1993). For instance, theC-terminusof theprotein
C contains an internal hydrophobic signal sequence responsible for
translocating the prM protein into the lumen of the ER. On the
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ytosolic side of the ER membrane, protein C is cleaved off the sig-
al sequence by NS2B/3pro (Amberg et al., 1994; Yamshchikov and
ompans, 1994). This cleavage is a prerequisite to allow the host
ell SPaseI cleavage at the signal sequence on the luminal side of the
R membrane to generate the N-terminus of protein prM. Initiation
f virion assembly has been proposed to depend upon the timing
f these cleavage events at the termini of the signal sequence sepa-
ating proteins C and prM (Amberg and Rice, 1999; Lee et al., 2000;
obigs and Lee, 2004; Stocks and Lobigs, 1998). Protein prM is in
ts turn a prerequisite to ensure correct synthesis and transport of
rotein E (Konishi and Mason, 1993; Lorenz et al., 2002).
In TBEV, investigation of the cleavage by NS2B/3pro in the C-
erminal region of protein C is complicated by the presence of two
otential cleavage sites (KR*G and RR*S, underlined in Fig. 2; Mandl
t al., 1991). Schrauf et al. (2009) showed that, in vivo, the down-
tream cleavage site is used and that the upstream cleavage motif
annot be accepted when the downstream cleavage motif had been
emoved by mutation.
Schrauf et al. (2009) showed further that, in the absence of the
ownstream NS2B/3pro cleavage site, the C-terminus of protein C
ould be released from the polypeptide chain by the introduction of
he foot-and-mouth disease virus (FMDV) 2A sequence. The pres-
nce of the sequence Asn-Pro-Gly-Pro at the C-terminus of this 20
mino acid protein causes the ribosome to pause, release the ﬁrst
rotein and then continue translation of the mRNA. In contrast,
pon removal of the residues Pro-Gly-Pro from the 20 amino acid
equence, the separation of C and prM was inhibited, leading to a
eplication deﬁcient virus. Virion production could be rescued by
he introduction of an FMDV 3Cpro cleavage site at the N-terminus
TBEV       --SFSEPLTVVGVMLTLASGMMRHTSQ
WNV        GWPATEVMTAVGLMFAIVGGLAELDID
A NS2B
. :* :*.**:*:::..*: .   :
TBEV       EWYPELVNEGGEVSLRVRQDAMGNFHL
WNV        TWESDAEITGSSERVDVRLDDDGNFQL
* .:    *..  : ** *  ***:*
TBEV GLWTLTEMLRSSRR 131
WNV        GFWIT---LQYTKR 131
*:*     *: ::*
B NS3 (N-termin al parts)
TBEV       SDLVFSGQGGRERGDRPFEVKDGVYR 
WNV        GGVLWDTPSPKEYKKG--DTTTGVYR
..:::.  . :*  .   :.. ****
TBEV       LSIDDAVAGPYWADVR EDVVCYGGAW 
WNV        LMSGEGRLDPYWGSVKEDRLCYGGPW
*  .:.  .***..*:** :****.*
TBEV       LDTGRKLGAIPIDLVKG TSGSPILNA
WNV        TPEG-EIGAVTLDYPTGTSGSPIVDK
* ::**:.:*  .*******:: 
TBEV       LPQAVVGTGWT SKGQITVLDMHPGSG 
WNV        -APAGFEPEMLRKKQITVLDLHPGAG
. * . .    * ******:***:*
ig. 1. Alignment of tick-borne encephalitis virus (TBEV) and West Nile virus (WNV) am
n  the formation of the active site in WNV  is underlined. (B) N-terminal portions of NS3. C
f  NS2B and NS3 used for constructing the recombinant TBEV NS2B/3 are green and red, 
olons and dots, respectively. (For interpretation of the references to colour in this ﬁgurech 168 (2012) 48– 55 49
of the 2A sequence and the expression of the 3Cpro either in cis from
a second ORF or in trans from a TBEV replicon (Schrauf et al., 2012).
However, we  were unable to achieve success in such a system with
the HIV-1pro (Schrauf et al., unpublished).
To enable a more predictable extension of this system to other
viral proteinases, we  decided to ﬁrst establish an in vitro biochem-
ical system that would allow the investigation of the parameters
required to ensure accurate proteolysis at the C-prM junction of
TBEV. In this report, we  describe such a system and use it to analyse
the membrane dependency of cleavage by the TBEV NS2/3pro.
2. Materials and methods
2.1. Oligonucleotides and plasmids
Oligonucleotide sequences can be found in Supplementary Table
1. Constructs encoding TBEV European subtype strain Neudörﬂ
(EMBL: U27495) were derived from pBR-TBEV-ME-E-EGFPo
(kind gift of Dr. P. Schlick). Plasmids coding for the co-factor and
the protease were constructed in two steps. First, the hydrophilic
cofactor region of NS2B (Fig. 1A), corresponding to amino acids
1404–1453 of the TBEV polyprotein (UniProt: P14336) was ampli-
ﬁed by primers NS2B-f and NS2B-r-3′ linker. These primers,
introducing an NcoI restriction site at the 5′ end and the ﬁrst half of
the synthetic linker containing an XmaI recognition sequence at the
3′ end, were used to clone the fragment into pCite-A1, designated
as pCite-A1-NS2B. Then, a fragment encoding the 190 N-terminal
residues of NS3 (Fig. 1B), the protease domain (UniProt: P14336,
residues 1490–1679) was ampliﬁed with primers 5′-Linker-NS3-F
EALCALAVASFLLLMLVLGTRKMQLVAEWSGCV 58
SMAIPMTIAGLMFAAFVISGKSTDMWIERTADI 60
.   .:::*.:::  :*:. :. ::  * :. :
TELEKEERMMAFWLIAGLAASAIH-WSGILGVM 11 7
MNDPGAPWKIWMLRMACLAISAYTPWAILPSVI 120
 :       : :  :* ** **   *: : .*:
IFSPGLFWGQNQVGVGYGSKGVLHTMWHVTRGA A 60
IMTRGLLG-SYQAGAGVMVEGVFHTLWHTTKGAA 57
*:: **:  . *.*.*   :**:**:**.*:***
SLEEKWKG-ETVQVHAFPPGRAHEVHQCQPGEL I 119
KLQHKWNGHDEVQMIVVEPGKNVKNVQTKPGVFK 117
.*:.**:* : **: .. **:  :  * :** : 
QGVVVGLYGNGLKT-NETYVSSIAQGEAEKSRP N 17 8
NGDVIGLYGNGVIMPNGSYISAIVQGERMEEP-- 17 4
:* *:******:   * :*:*:*.***  :.   
KTHRVLPELIRQCIDRRLRTLVLAPTRVVLKEME 238
KTRKILPQIIKEAINKRLRTAVLAPTRVVAAEMS 233
**:::**::*::.*::**** ********  **.
ino acid sequences. (A) Complete sequences of NS2B. A conserved region involved
atalytic triad residues (His 54, Asp 78 and Ser 138) are indicated in blue. The parts
respectively. Identical, very similar and similar residues are indicated by asterisks,
 legend, the reader is referred to the web version of this article.)
50 M. Kurz et al. / Virus Research 168 (2012) 48– 55
Fig. 2. (A) Variants of recombinant proteases. The 49 amino acid residue-long, central portion of NS2B was linked with the NS3pro sequence via a GASPGGSGA or GGGGSGGGAG
linker,  respectively. All protease constructs were C-terminally tagged with a (his)×6 tag. The arrow indicates the position of the ﬁrst amino acid found in the 28 kDa band
examined by mass spectroscopy. (B) Schematic diagram of the TBEV polyprotein with cleavage sites for the viral protease (black arrowhead), host signal peptidase I (blue
arrowhead) and furin (diamond). (C) Variants of substrates used in this study. Schematic drawing of the C-terminal region of the capsid protein and the signal sequence for
prM  (not drawn to scale). Engineered mutations are shown together with the corresponding designations. The potential but unused upstream NS2B/3pro cleavage site (KRG)
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f  the references to colour in this ﬁgure legend, the reader is referred to the web  ve
nd NS3-R-6xHis. Thereby, the second half of the synthetic linker
ontaining an XmaI recognition site was introduced at the 5′-end of
he protease region. Furthermore, six histidine codons and a BamHI
ite were added to the 3′-end. These enzymes were used to ligate
he protease domain to pCite-A1-NS2B, ﬁnally named pCite-A1-
S2B/3, coding for the tethered NS2B/3 protease (Fig. 2A).
NS2B/3 S135A with alanine substitutions at S135 in the catalytic
riad of NS3 were made by site-directed mutagenesis with primers
S3 S135A-f and NS3 S135A-r.
To generate the stabilised proteases with the new linker
GGGSGGGG, a cleavage site for BglII was introduced downstream
f the linker with primers NS3-BglI-f and NS3-BglI-r. Cassettes cod-
ng for the desired mutations K90A and R93A of NS2B as well as
he new linker were designed and introduced by use of the BglII
nd XhoI. The mutation G to A in the linker region of construction
S2B/3 R93A occurred serendipitously during mutagenesis. As the
nsuing protease proved to be stable and active, it was  used in all
ubsequent experiments.
For expression in E. coli, sequences coding for the desired
ethered proteases were cloned from pCite-A1-NS2B/3 into the
xpression vector pET11d by use of NcoI and BamHI.
To generate the plasmids coding for the substrates (Fig. 2B and
), plasmid pTNd/5 which contains the 5′-part of the genome of
BEV European subtype strain Neudörﬂ, was used as template (kind
ift of Dr. R. Koﬂer). Using primers C-prM-f and C-prM-r, we pro-
uced PCR fragments encoding the capsid protein, transmembrane
egion and pre-membrane protein prM. Thus, C-prM corresponds
o residue 1–280 of the TBEV polyprotein. The plasmid was named
Cite-C-prM.
To generate pCite-C-2A3-prM and pCite-C-HIV-prM, we used
lasmid pBR-C-2A3-prM and pBR-C-HIV-prM, both kind gifts of
r. S. Schrauf. By use of AgeI and MluI, we isolated the desired
ragment and cloned it into pCite-C-prM using the same cleavage
ites. of NS2B/3 (black), and cleavage sites of SPaseI (blue) and HIV-1 protease (red) are
tein C or prM. The transmembrane region is highlighted in blue. (For interpretation
of this article.)
In order to inhibit signal peptidase cleavage, nine leucine
residues were introduced into the transmembrane regions of sub-
strates by use of primers TM-9L-f and TM-9L-r.
2.2. In vitro transcription and translation
All pCite plasmids were linearised with BamHI. In vitro tran-
scription with T7 RNA polymerase and in vitro translation were as
described in Schlick et al. (Schlick and Skern, 2002). In vitro trans-
lation reactions (typically 20 l) contained 70% RRL (Promega),
20 Ci of 35S-methionine (1000 Ci/mmol, American Research Com-
pany) and amino acids (except methionine) at 20 M.  After
pre-incubation for 1 min  at 30 ◦C, translation was started by addi-
tion of RNA. The reaction was  stopped at designated time points by
immediate transfer to ice and addition of unlabelled methionine
and cysteine to a ﬁnal concentration of 2 mM.  Where indicated,
translation reactions were supplemented with 4–8% pancreatic
microsomal membranes (Promega).
2.3. Protease assay
For self-cleavage reactions, translation products with or with-
out microsomal membranes were incubated in assay buffer (20 mM
Tris/HCl, pH 7, 50 mM NaCl) at 30 ◦C and quenched by addition of
an SDS–PAGE loading buffer to a ﬁnal concentration of 2% SDS.
Trans-cleavage reactions were performed at 30 ◦C in a ﬁnal vol-
ume  of 10 l containing substrate and puriﬁed NS2B/3pro at the
indicated ﬁnal concentrations and assay buffer. After the indicated
times, the reaction was  stopped by addition of SDS sample buffer.2.4. Electrophoresis and immunoblotting
The polyacrylamide gel electrophoresis system of Dasso and
Jackson (1989), containing 15% polyacrylamide, was  used to
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eparate proteins. 35S-containing proteins were detected by ﬂu-
rography.
.5. Expression and puriﬁcation
The plasmids pET 11d-NS2B/3, pET 11d-NS2B/3 S135A, pEt11d-
S2B/3 R93A were used for high-level, inducible expression of
exa-histidine-tagged recombinant proteins. Cultures of E. coli
train BL21(DE3)pLysS transformed with the expression plasmids
ere grown in 10 ml  of LB medium containing 34 g/ml chloram-
henicol and ampicillin at 37 ◦C overnight. This overnight culture
as diluted 1:100 in fresh LB medium containing chloramphenicol
nd ampicillin at the concentrations stated above and incubated
t 37 ◦C, 225 rpm until an OD600 of 0.5–0.6 had been reached. The
xpression of the recombinant proteins was induced by addition
f isopropyl--d-thiogalactopyranose (IPTG) to a ﬁnal concentra-
ion of 0.1 mM.  Cultures were incubated for additional 4 h, and
ells were harvested by centrifugation. Cell pellets were resus-
ended in 30 ml  resuspension buffer containing 50 mM Tris–HCl,
0 mM  NaCl, pH 8 and lysed with a Bandelin Sonoplus sonicator (4
ycles, 40%, 30 s and once continuous for 30 s) and centrifuged at
5,000 rpm for 30 min  at 4 ◦C. The supernatant was loaded onto a
 ml  HiTrap chelating column (GE Healthcare) loaded with nickel
nd pre-equilibrated with lysis buffer. The protein was eluted with
 linear gradient of 0–500 mM imidazole in lysis buffer. Fractions
ontaining NS2B-NS3 proteins, determined by 12.5% SDS–PAGE,
ere pooled and concentrated using Amicon Ultra-4 Centrifugal ﬁl-
er Device 10 kDa cut-off (Millipore). Subsequently, the protein was
oaded on to a HiLoad TM 26/60 Superdex 75 column (GE Health-
are) equilibrated with resuspension buffer and run according to
he manufacturer’s instructions. Fractions were again analysed by
DS-PAGE. Aliquots were stored until use at −80 ◦C.
.6. Expression and puriﬁcation of the HIV-1pro
Penta-stabilised HIV-1pro Q7K, L33I, L63I C67 C95A was a kind
ift of Dr. J. Tözsér (Louis et al., 1999). Brieﬂy, the protease was
xpressed in E. coli and refolded by dialysis against 25 mM formic
cid for 2 h and then against 100 mM Na-acetate-trihydrate, 1 mM
TT, 1 mM  EDTA, 10% glycerol and 0,03% Triton X-100, pH 5 ﬁve
imes for 2 h. The ﬁnal concentration of the enzyme was 0.4 U/l.
his buffer was also used in HIV-1pro trans-cleavage experiments.
. Results
.1. Generation of an active TBEV NS2B/3pro
The proteolytic domain of the multifunctional ﬂaviviral NS3
rotein serine protease resides in the amino-terminal domain. The
rotein folds into two -barrels with the hydrophilic core being
tabilised by the co-factor NS2B which also plays a role in substrate
inding (Erbel et al., 2006). Without the NS2B domain, the NS3
rotease is proteolytically inactive. It has been shown by Leung
t al. (2001) that the cofactor activity of the NS2B core region
residue 35–48) is comparable to that of the entire NS2B sequence.
his knowledge allowed single chain NS2B/3pro to be generated by
enetically fusing the NS2B core region to the NS3 protease domain
y a short linker region. Indeed, NS2B/3pro of several ﬂaviviruses
ave been expressed in this way (Bessaud et al., 2005; Leung et al.,
001; Nall et al., 2004; Shiryaev et al., 2006; Yusof et al., 2000). To
enerate a similar construction for TBEV, the pertinent regions of
S2B and NS3 in the TBEV polyprotein were analysed by sequence
lignment with WNV  (Fig. 1) and related ﬂaviviruses (data not
hown). Residues 46–94 of TBEV NS2B (in green in Fig. 1A) and
esidues 1–190 (in red in Fig. 1B) of NS3 were identiﬁed bych 168 (2012) 48– 55 51
similarity to the regions employed in WNV  (Nall et al., 2004) as
the central hydrophilic co-factor region of NS2B and the protease
domain of NS3, respectively. These regions were ampliﬁed by
PCR as indicated in Section 2.1 and linked by a DNA sequence
encoding the ﬂexible linker indicated in Fig. 2A. To prevent the
loss of the NS2B activating peptide through autocatalytic cleavage,
we attempted to ensure that no cleavage site for the NS3 protease
was  present in the ﬂexible linker. A C-terminal hexa-histidine
tag was  introduced at the C-terminus for puriﬁcation. A similar
construct containing the inactivating mutation S135A was also
prepared. Both wild-type and the inactivated mutant could be
produced either by in vitro transcription and translation assay in
rabbit reticulocyte lysates (RRLs) or by expression in E. coli.
To test whether the NS2B/3 hybrid protein was indeed stable,
the NS2B/3pro and NS2B/3pro S135A RNAs were translated in RRL
in the presence of 35S methionine for 30 min at 30 ◦C followed by
addition of unlabelled methionine and incubation at 30 ◦C for the
indicated times. Synthesised proteins were separated by SDS-PAGE
and detected by ﬂuorography. Both NS2B/3pro and NS2B/3pro S135A
RNAs were translated into a protein of 33 kDa, slightly higher than
the calculated Mr  of 28 kDa. During the incubation of the active
protease, the 33 kDa band slowly disappeared overnight and was
replaced by bands of apparent molecular weight 28 kDa and 12 kDa.
However, as the smaller band was  actually running with the buffer
front of the gel, its molecular weight cannot be given with any conﬁ-
dence. In contrast, the 33 kDa band of the inactive NS2B/3pro S135A
remained stable (Fig. 3), suggesting that autolysis of the active pro-
tease was responsible for the conversion of the 33 kDa species into
the two smaller ones.
Similar results were obtained using the bacterially expressed
NS2B/3pro (data not shown). Mass spectroscopy of the puriﬁed
28 kDa band from SDS-PAGE revealed that it lacked the N-terminal
47 amino acids of the NS2B/3 active proteinase (see Fig. 2).
Thus, despite the lack of a corresponding cleavage site, the active
NS2B/3pro was  still able to perform autolysis between residues K90
and E91 (Figs. 2 and 3), giving rise to fragments of calculated Mr  22
and 6 kDa, respectively. To prevent such autolysis, we  constructed
two  modiﬁed NS2B/3 proteins in which either one (R93A) or two
(K90A R93A) basic residues at the C-terminus of 2B were replaced
with alanine (Fig. 2A). In addition, the linker sequences were also
modiﬁed to more closely resemble that used in other ﬂaviviral
NS2B/3 constructs (Fig. 2A; Leung et al., 2001; Nall et al., 2004).
RNA from the resulting constructs NS2B/3pro R93A and NS2B/3pro
K90A R93A was translated in RRLs; both synthesised proteins were
stable over the time-course of the experiment (Fig. 3). NS2B/3pro
R93A was selected for use in all subsequent experiments.
3.2. In vitro processing of the structural protein precursor C-prM
The precursor (C-prM) of C and prM is connected by a short
hydrophobic domain that spans the membrane of the ER (Fig. 4A).
C is cleaved into its mature form by the NS2B/3pro at the cytosolic
side whereas the SPaseI cleaves prM to its mature form in the ER
(Fig. 4A as well as 2B and 2C). SPaseI only gains access to its cleav-
age site once NS2B/3pro has cleaved at the C-terminus of protein C.
To investigate this cleavage reaction in vitro, we incubated puriﬁed
recombinant NS2B/3pro R93A with C-prM synthesised in RRL. Con-
trol experiments were performed with buffer or with recombinant
inactive NS2B/3 S135Apro (ﬁnal concentration 1 g/l). Proteins
were separated by SDS-PAGE and detected by ﬂuorography.
A single speciﬁc band corresponding to unprocessed C-prM
running at 35 kDa was  detected when the substrate was incubated
with buffer or inactive NS2B/3pro (Fig. 4B, lanes 2–4 and data not
shown). When incubated with active NS2B/3pro at a ﬁnal concen-
tration of 1 g/l (Fig. 4B, lanes 5–8), the substrate was  converted
into two bands running at 27 kDa, corresponding to prM* (prM
52 M. Kurz et al. / Virus Research 168 (2012) 48– 55
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pig. 3. Analysis of autocatalytic activity of TBEV NS2B/3pro. In vitro transcribed RNAs 
or  30 min  at 30 ◦C. Following the addition of unlabelled methionine, samples were
.  Proteins were separated by SDS-PAGE and 35S-containing proteins detected by ﬂ
lus amino-terminal transmembrane region), and about 10 kDa,
orresponding to protein C. We  tested several assay conditions to
ptimise the cleavage efﬁciency but were not able to ﬁnd condi-
ions in which amounts of protein less than 1 g/l  led to cleavage.
hus, the cleavage efﬁciency of the puriﬁed protease remained
ather low in comparison with recombinant proteases from related
iruses (Bera et al., 2007; Chappell et al., 2008; Shiryaev et al.,
007).
.3. NS2B/3pro cleavage of prM in vitro does not depend on the
resence of its cleavage site
The canonical NS2B/3pro recognition site in the C-terminal
egion of protein C of TBEV was shown previously to be at R-R*S
Schrauf et al., 2008; Fig. 2C). To test whether the cleavage of C-
rM by NS2B/3pro was dependent on the presence of its cleavage
ite, we generated a C-prM mutant (C-2A3-prM) in which the
ownstream NS2B/3pro cleavage site was replaced by a version of
he 2A sequence of foot and mouth disease virus (FMDV) lacking
he characteristic Pro-Gly-Pro motif at its C-terminus (see Fig. 2C).
his form is unable to allow the ribosomes to skip the formation
f a peptide bond so that protein C cannot be released from the
olyprotein (Donnelly et al., 2001). A TBEV mutant bearing this
runcated 2A (C-2A3-prM) was replication deﬁcient, as protein
 could not be processed by the NS2B/3pro (Schrauf et al., 2009).
his provides further evidence that the upstream cleavage site is
ot used. Nevertheless, in this in vitro system described here, we
bserved, in the absence of the downstream cleavage site at the
-terminus of protein C, cleavage of the C-2A3-prM with puriﬁed
S2B/3pro (Fig. 4C, lane 3). The most likely interpretation is that the
pstream cleavage was substituting for the downstream site.It should be noted that, despite repeated attempts, we  were not
ble to detect the cleavage product for protein C. We  interpret this
ailure to mean that the modiﬁed protein C containing all or part
f the 2A protein of FMDV is unstable in RRLs. We  have observed
ig. 4. Processing of TBEV polyprotein subfragments containing the C and prM proteins b
C)  C-2A3-prM. In vitro translated substrates were incubated with buffer or NS2B/3pro
roteins detected by ﬂuorography.ing the indicated proteins were translated in RRLs in the presence of 35S-methionine
ated for the indicated times in buffer containing 50 mM NaCl, 50 mM Tris/HCl, pH
raphy.
this phenomena previously when expressing other viral proteins
in this system (Sousa et al., 2006).
3.4. Signal peptidase cleavage of C-prM in the presence of
microsomal membranes occurs in the absence of NS2B/3pro
cleavage
We  postulated that the speciﬁcity of the NS2/3pro reaction could
be increased by the addition of canine pancreatic microsomal mem-
branes (subsequently referred to as membranes) to allow the signal
peptide that separates the two proteins to insert into a membrane.
Upon translation of C-prM in the presence of the above-mentioned
membranes for 30 min, a decrease in its electrophoretic mobil-
ity could clearly be seen after a further 60 min of incubation at
30 ◦C (Fig. 5A, compare lane 2 with lane 3), suggesting that N-
glycosylation had occurred at residue Asp 144 of prM (Fig. 5A, lane
3). After 120 min, however, the amount of the C-prM species had
decreased; instead, a new band had appeared at 28 kDa. Based on
the molecular weight, we  suggest that this corresponds to glycosy-
lated prM lacking the trans-membrane region (Fig. 5A, lane 4).
The most likely explanation for the above result is that the mem-
brane bound signal peptidase (SPaseI) has processed its luminal
cleavage site in the absence of the viral protease. According to
previous studies, however, the SPaseI cleavage should not occur
until the NS2B/3pro has performed processing at the C-terminus of
protein C (Lobigs, 1993; Lobigs and Lee, 2004; Stocks and Lobigs,
1995). As we wished primarily to investigate NS2B/3pro cleavage,
we looked for an approach to inhibit the SPaseI reaction whilst
permitting the cleavage by NS2B/3pro. To this end, we ﬁrst used
a known inhibitor of SPaseI, N-methoxysuccinyl-Ala-Ala-Pro-Val-
chloromethyl ketone (Lundin et al., 2008; Nilsson et al., 2002).
Indeed, this compound, at concentrations of 750 M or higher, did
inhibit the proposed SPaseI cleavage reaction (data not shown).
However, this concentration also inhibited the activity of NS2B/3pro
(data not shown), leading to the abandonment of this approach.
y puriﬁed recombinant NS2B/3pro. (A) Topology of the C-prM-E region. (B) C-prM.
for the indicated times. Proteins were separated by SDS-PAGE and 35S-containing
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still accessible even in the presence of membranes. Nevertheless,
this experiment shows clearly that it is possible, at least in vitro,
to make the cleavage between proteins C and prM dependent on
HIV-1pro.
Fig. 6. Effect of the replacement of the NS2B/3 cleavage site in C-9L-prM with thatig. 5. Effect on proteolytic processing of the synthesis of C-prM subfragments in t
t  30 ◦C for the indicated times. (B) C-9L-prM was synthesised in the presence or a
ndicated concentrations and times at 30 ◦C. Proteins were separated by SDS-PAGE 
We  therefore took an alternative approach to eliminate SPaseI
leavage. Signal peptides have been shown to possess a common
tructure, namely a short, positively charged amino-terminal n-
egion, a central hydrophobic h-region (blue in Fig. 2B and C) and
 polar, mostly uncharged c-region containing the signal peptidase
leavage site. In addition to certain other differences, one appre-
iable difference between cleaved signal peptides and non-cleaved
ignal anchors is the length of the h-region. Consequently, it is
ossible to convert a signal peptide into a signal anchor by length-
ning its h-region (Nilsson et al., 1994). To this end, we introduced
 stretch of nine leucine residues into the h-region of the signal
eptide between C and prM (Fig. 2C). RNA from this construct,
ermed C-9L-prM, was then incubated in RRLs in the presence of
icrosomal membranes and the stability of the translated protein
xamined. Fig. 5B shows that the protein remained intact in both
he absence (lanes 2 and 3) and presence of membranes (lanes 7 and
), indicating that extension of the h-region conveyed resistance to
PaseI cleavage.
It is worth noting that, in this experiment, the glycosylation
as complete during the translation phase of the reaction (com-
are Fig. 5A, lane 2 with Fig. 5B, lane 7) and that there was hardly
ny detectable difference between the protein in the glycosy-
ated and non-glycosylated form (compare left and right panels of
ig. 5B).
.5. NS2B/3pro shows higher activity and speciﬁcity in the
resence of microsomal membranes
Having generated a form of C-prM that was resistant to cleav-
ge by SPaseI, we could now examine its ability to act as substrate
or NS2B/3pro. We  therefore incubated C-9L-prM that had been
ranslated in the absence or presence of microsomal membranes
ith different concentrations of NS2B/3pro. Interestingly, the con-
entration of NS2B/3pro could be reduced by 10–20-fold (compare
ig. 5B, lanes 4 and 5 with lanes 9 and 10) when microsomal mem-
ranes were used. NS2B/3pro at a ﬁnal concentration of 500 ng/l
Fig. 5B, lane 4) was required to cleave C-9L-prM in the absence
f membranes, whereas 25 ng/l (Fig. 5B, lane 10) were sufﬁ-
ient to obtain cleavage of this substrate when membranes were
sed.
To conﬁrm that the NS2B/3pro enzyme was  indeed recognis-
ng the correct cleavage site, we designed a C-9L-prM mutant in
hich the downstream NS2B/3pro cleavage site was  replaced by a
leavage site of the HIV-1pro (C-HIV-9L-prM). Fig. 6 (lanes 4 and
) shows that the protein is not cleaved by NS2B/3pro in the pres-
nce of membranes, even though the upstream cleavage site was
till available. However, once again cleavage was  observed in the
bsence of membranes (Fig. 6, lane 8).
Thus, we concluded from the above set of experiments that the
S2B/3pro was indeed recognising its true cleavage site but only in
he presence of membranes.sence of microsomal membranes. (A) C-prM. Translation products were incubated
 of microsomal membranes and then incubated in buffer or with NS2B/3pro at the
S-containing proteins detected by ﬂuorography.
3.6. The cleavage between C and prM can be performed by
HIV-1pro
The presence of the HIV-1pro cleavage site in C-HIV-9L-M
allowed us to investigate whether C-HIV-9L-prM was cleaved by
HIV-1pro in the presence or absence of membranes. As a control, we
used the construction C-9L-prM lacking the HIV-1pro cleavage site.
In the absence of microsomal membranes, both constructs were
processed by the HIV-1pro (Fig. 7A, lanes 2–5), showing a simi-
lar pattern of two cleavage products of about 28 kDa and 20 kDa.
The 28 kDa band presumably arises through cleavage at the C-prM
junction to give prM*, whereas the 20 kDa band indicates cleav-
age at a position within protein C or prM. To verify that HIV-1pro
is responsible for the cleavages, we added increasing concentra-
tions of pepstatin, a known HIV-1pro inhibitor (Wondrak et al.,
1991). Fig. 7B indeed shows a concentration dependent inhibition
of cleavage, indicating that the cleavage is indeed due to HIV-1pro
processing.
Next we investigated HIV-1pro cleavage in the presence of
microsomal membranes (Fig. 7A, lanes 6–8). Cleavage of the C-
9L-prM construct was no longer observed (upper panel); however,
with the C-HIV-9L-prM construct, the same cleavage products were
observed as in the absence of membranes (lower panel). Thus,
the presence of the membranes eliminated any cleavage of the C-
prM construct lacking the HIV-1pro site, suggesting that the protein
was  correctly inserted in the membrane. In addition, the cleavage
products obtained with the C-HIV-9L-prM indicate that correct pro-
cessing at the HIV-1pro sequence was  occurring, but suggested that
a second cleavage site was  present within the prM protein that wasof  HIV-1pro on NS2B/3pro processing. C-HIV-9L-prM was translated in the presence
(lanes 2–5) or absence (lanes 6–8) of microsomal membranes and incubated with
buffer or NS2B/3pro at the indicated ﬁnal concentrations and for the indicated times
at  30 ◦C. Proteins were separated by SDS-PAGE and 35S-containing proteins detected
by  ﬂuorography.
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Fig. 7. Cleavage at the TBEV C-prM junction by HIV-1pro. (A) HIV-1pro cleavage in the absence (lanes 2–5) and presence (lanes 6–8) of microsomal membranes. C-9L-prM
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tupper  panel) and C-HIV-9L-prM (lower panel) were translated with or without m
anes  5 and 8, 2.8 mU/l) for 30 min  at 30 ◦C. (B) C-HIV-9L-prM was translated in th
he  absence or presence of pepstatin at the indicated concentrations. Proteins were
. Discussion
We present here a system in which the cleavage in the C-
erminal region of protein C of TBEV can be speciﬁcally performed
y puriﬁed recombinant viral NS2B/3 protease. Such cleavage
equired the presence of microsomal membranes to prevent non-
peciﬁc proteolysis by the NS2B/3pro as well as introduction of
ine leucine residues at the C-terminus of the transmembrane
egment of protein C to prevent incorrect SPaseI cleavage. Cleav-
ge of the protein C-9L-prM in the presence of membranes was
fﬁcient and speciﬁc, requiring only 25 ng/l to initiate cleavage
Fig. 5B, lane 10). When the NS2B/3pro cleavage site was replaced
y that of the HIV-1pro cleavage site, the C-9L-prM protein was  still
leaved by NS2B/3pro in the absence of microsomal membranes.
owever, in the presence of microsomal membranes, no cleavage
ith NS2B/3pro was observed, demonstrating the dependence of
S2B/3pro speciﬁcity on the presence of membranes. Instead, cleav-
ge between C and prM could now be carried out by the HIV-1pro.
owever, a second cleavage was observed with the HIV-1pro both
n the presence and absence of membranes. This may  explain why
t was not possible to make a TBEV that was dependent on cleavage
ith HIV-1pro as was the case for FMDV 3Cpro (Schrauf et al., 2012).
To establish this system, a number of difﬁculties had to be over-
ome. Firstly, the modular NS2B/3 protein that we constructed was
apable of undergoing autocatalytic cleavage, even in the absence
f a dibasic sequence in the proximity of the linker. This reaction
ould be prevented by the substitution of an arginine residue (R93)
wo amino acids upstream of the synthetic linker. This suggests that
he presence of this basic residue, coupled with the proximity of the
inker to the active site, allowed slow autoproteolytic cleavage to
ake place on a non-canonical cleavage sequence.
This recombinant NS2B/3pro was puriﬁed to homogeneity and
as able to cleave speciﬁcally in the C-terminal region of protein
, provided that translation took place in the presence of micro-
omal membranes and that SPaseI cleavage had been prevented
y extension of the trans-membrane helix. This is in contrast to
xperiments that examined the cleavage of West Nile virus C-
rM using infected cells as a source of the active WNV  NS2B/3pro
Yamshchikov and Compans, 1994) and suggests a fundamental
ifference in the cleavage of two viral polyproteins.
Substitution of the NS2B/3pro cleavage motif in C-prM by that
f HIV-1pro allowed us to examine cleavage of C-HIV-9L-prM by
he HIV-1pro in the presence of membranes. In addition to amal membranes and incubated with puriﬁed HIV-1 (lanes 4 and 7, 5.7 mU/l;
ence of microsomal membranes and incubated for 60 min  at 37 ◦C with HIV-1pro in
ated by SDS-PAGE and 35S-containing proteins detected by ﬂuorography.
band corresponding to prM*, indicating cleavage at the HIV-1pro
sequence, an additional cleavage product with a size of about
20 kDa was  observed. Where might the HIV-1pro additional HIV
cleavage sequence be located? Sequence analysis via an online
HIV-1pro cleavage site prediction program (Chou, 1996; Chou et al.,
1993; Shen and Chou, 2008) revealed a TVIR/AEGK motif spanning
amino acids 134–143 with a high probability of cleavage by HIV-
1pro. Cleavage at this site in prM would result in the formation of
two  bands of 20 and 6 kDa, respectively, in good agreement with
the observed 20 kDa band; the 6 kDa product would not be retained
on the polyacrylamide gel. However, this site on the prM protein
should be inside the membrane vesicles and not available for the
protease. In contrast, the construction of C-9L-prM without an HIV-
1 site was  not cleaved by HIV-1pro in the presence of membranes.
This implies that there is a difference in the orientation of the two
proteins in the membrane that can only derive from the presence of
the HIV-1pro cleavage site in the C-terminal region of protein C. This
mis-orientation of the polyprotein containing the HIV-1pro cleavage
site may  explain why  it was not possible to obtain virions when we
tried to make the C-prM cleavage dependent on the HIV-1pro in cell
culture using a bi-cistronic virus (Schrauf et al., unpublished). As
the cleavage at the C-terminus was  possible with the FMDV 3Cpro
(Schrauf et al., 2012), the failure with the HIV-1pro must lie with
this enzyme and/or with its cleavage site and not with the system
per se.
This system has allowed us to demonstrate the membrane
dependency of cleavage speciﬁcity of TBEV NS2B/3pro at the C-prM
junction. In future, this system should also serve as a model to
examine the topology of the transmembrane anchor of the TBEV
protein C and the requirements for correct SPaseI processing.
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